Kara Chung1, Henry Rafferty2, Leslie W Suen1,3, Maya Vijayaraghavan1. 1. University of California, San Francisco, San Francisco, CA, USA. 2. San Francisco Department of Public Health, San Francisco, CA, USA. 3. San Francisco Veteran Affairs Medical Center, San Francisco, CA, USA.
Abstract
INTRODUCTION: The shift from in-person care to telemedicine made it challenging to provide guideline-recommended tobacco cessation care during the COVID-19 pandemic. We described quality improvement (QI) initiatives for tobacco cessation during the COVID-19 pandemic, focusing on African American/Black patients with high smoking rates. METHODS: The QI initiatives took place in the San Francisco Health Network, a network of 13 safety-net clinics in San Francisco, California between February 2020 and February 2022. We conducted direct patient outreach by telephone and increased staff capacity to increase cessation care delivery. We examined trends in tobacco screening, provider counseling, and best practice for cessation care (ie, the proportion of patients receiving at least 1 smoking cessation service during a clinical encounter). RESULTS: In-person visits at the onset of the pandemic was 20% in April 2020 and increased to 67% by February 2022. During this time, tobacco screening increased from 29% to 74%. From March 2020 to March 2021, 34% more patients received provider counseling by telephone than in-person. The trend reversed from April 2021 to February 2022, where 23% more patients received counseling in-person than by telehealth. Best practice care increased by 23% from June 2020 to February 2022: 24% for African American/Black patients and 23% for other patients. CONCLUSIONS: Telehealth adaptations to the EHR, targeted outreach to patients, and a multi-disciplinary medical team may be associated with increases in cessation care delivery during the COVID-19 pandemic.
INTRODUCTION: The shift from in-person care to telemedicine made it challenging to provide guideline-recommended tobacco cessation care during the COVID-19 pandemic. We described quality improvement (QI) initiatives for tobacco cessation during the COVID-19 pandemic, focusing on African American/Black patients with high smoking rates. METHODS: The QI initiatives took place in the San Francisco Health Network, a network of 13 safety-net clinics in San Francisco, California between February 2020 and February 2022. We conducted direct patient outreach by telephone and increased staff capacity to increase cessation care delivery. We examined trends in tobacco screening, provider counseling, and best practice for cessation care (ie, the proportion of patients receiving at least 1 smoking cessation service during a clinical encounter). RESULTS: In-person visits at the onset of the pandemic was 20% in April 2020 and increased to 67% by February 2022. During this time, tobacco screening increased from 29% to 74%. From March 2020 to March 2021, 34% more patients received provider counseling by telephone than in-person. The trend reversed from April 2021 to February 2022, where 23% more patients received counseling in-person than by telehealth. Best practice care increased by 23% from June 2020 to February 2022: 24% for African American/Black patients and 23% for other patients. CONCLUSIONS: Telehealth adaptations to the EHR, targeted outreach to patients, and a multi-disciplinary medical team may be associated with increases in cessation care delivery during the COVID-19 pandemic.
Entities:
Keywords:
primary care health systems; quality improvement; tobacco use interventions
In 2019, an estimated 34.1 million adults (14%) reported tobacco use in the
United States (US).[1,2] Tobacco use is concentrated in low-income
populations, including some racial/ethnic minority groups who report higher
rates of tobacco use than the general population.
Despite smoking fewer cigarettes per day, African American/Black
individuals who smoke experience higher morbidity and mortality from tobacco
use than White individuals.Populations with high medical comorbidities and social needs seek healthcare in
safety-net health systems, where the economic toll of smoking is
high.[4,5] Medicare and Medicaid contribute nearly 60%
($109 billion) of the annual health care costs from smoking-related conditions.
A 1% reduction of smoking prevalence is associated with $2.5 billion
in annual Medicaid savings,
highlighting a role for safety-net health systems to increase
delivery of guideline-recommended cessation programs.Safety-net health systems that are community-based and patient-centered are
best poised to serve patients with high social and medical needs.[5,9,10]
These health systems deliver comprehensive care through medical teams that
include healthcare providers, pharmacists, psychologists, social workers,
and ancillary staff.[11,12] Medical teams can
use their electronic health records (EHR) to receive automatic reminders for
tobacco screening,
refer for smoking cessation services (eg, behavioral counseling and pharmacotherapy),
and monitor receipt of services.[15,16] While health
systems have optimized their in-person delivery of smoking cessation care,
they have had to make adaptations for telehealth during the COVID-19
pandemic.[17
-20]Studies have highlighted a role for telehealth in providing cessation care,
particularly during the pandemic when health systems resources were
constrained. In Virginia, a military health facility used social media,
email, and online patient portals to inform patients of cessation resources.
After transitioning to a telephone tobacco counseling program, a
cancer center in New York reported improved patient engagement via telephone
more so than in-person counseling.
However, less is known about how safety-net systems have delivered
cessation services while adapting to telehealth during the COVID-19
pandemic.In this study, we describe telehealth adaptations and quality improvement (QI)
initiatives to improve delivery of tobacco cessation services in a safety
net health system in San Francisco, CA, during the COVID-19 pandemic. We
conducted direct patient outreach by telephone and improved staff capacity
to deliver cessation care. We examined trends in tobacco screening, provider
counseling, and best practice for delivery of smoking cessation care. Given
the high rates of tobacco use among Black/African American patients in our
safety net health systems, we examined differences in delivering best
practice care for Black/African American versus other patients.
Methods
Setting and Participants
The San Francisco Health Network (SFHN) annually serves nearly 60 000
low-income and racially/ethnically diverse patients, including over
7000 patients who smoke, across 13 primary care clinics. Of the 13
clinics, 4 were academic practices housed in a university-affiliated
public hospital (smoking prevalence 7%-34%). The other 9 were
community health clinics located across San Francisco (smoking
prevalence 10%-41%). We extracted data on tobacco screening and
delivery of cessation services from the EHR between February 2020 and
February 2022. The University of California, San Francisco
Institutional Review Board (#18-26398) considered the study
exempt.
Tobacco Cessation Care Model Before the COVID-19 Pandemic
Before the pandemic, medical teams delivered smoking cessation services
in person. Medical assistants (frontline staff) screened all patients
for tobacco use and referred those who smoked to Kick It California,
formerly known as the California Smokers’ Helpline (“Helpline”).
Healthcare providers counseled patients and prescribed
cessation medications during clinical encounters. Behavioral
assistants (ancillary staff at the health coach level) provided
cessation coaching using motivational interviewing to patients who
were referred to them by medical assistants and healthcare providers.
Members of the medical team were located in the same clinic, allowing
for easy coordination of cessation care through in-person hand-offs
between team members. We also built a single-click option within the
EHR for each clinical staff to document tobacco screening and delivery
of cessation services during each clinical encounter.In August 2018, we built a general tobacco registry embedded within the
EHR that included a list of all smoking patients who had not received
cessation care in the past 2 years, a pay-for-performance metric for tobacco.
The registry included demographic information, current smoking
status, the most recent primary care visit date, and the dates when
they received cessation services (eg, medical assistant referral,
healthcare provider, and behavioral assistant coaching). The medical
team accessed the tobacco registry to reach patients during and
between clinic visits. We operationalized the registry by (1)
populating the registry data, (2) validating the registry data by
chart review, (3) creating lists of patients who had not received
services, and (4) using the lists to make practice changes (eg,
training medical teams to document delivery of counseling in the
EHR).
Tobacco Cessation Care Model During the Pandemic
During the pandemic, clinic operations transitioned to a telehealth
model, with staff and providers delivering care by telephone. To adapt
to this model, we adopted new practices to ensure that cessation
services were provided and documented appropriately in the EHR. We
conducted direct patient outreach by telephone and improved staff
capacity to deliver cessation care via telephone encounters.
Patient outreach
We developed a patient registry that included all adult patients at
risk of contracting COVID-19 due to medical comorbidities (ie,
congestive heart failure, chronic obstructive pulmonary disease,
asthma, diabetes, or HIV). We included information on patient
demographics and smoking status in this registry, recognizing
that each outreach attempt to patients was an opportunity to
also discuss tobacco use. Medical assistants conducted telephone
outreach to patients in the registry to inform them about
COVID-19 services, and referred those with medical or behavioral
health needs to an appropriate clinical team member. Patients in
the registry who were current smokers also received resources
for smoking cessation including a referral to the Helpline
during the outreach phone call. We used this same process for
other patient outreach efforts during the COVID-19 pandemic. For
example, we conducted a telephone outreach to patients who had
uncontrolled diabetes and hypertension, who had food insecurity,
and to increase COVID-19 vaccinations, and with each of these
outreach efforts, patients who were smokers also received
resources for smoking cessation (Figure 1).
Figure 1.
Timeline of quality improvement initiatives to increase
delivery of tobacco cessation services at the San
Francisco Health Network during the COVID-19
pandemic. Patient outreach efforts are above the
timeline axis, staff capacity building efforts are
below the axis.
Timeline of quality improvement initiatives to increase
delivery of tobacco cessation services at the San
Francisco Health Network during the COVID-19
pandemic. Patient outreach efforts are above the
timeline axis, staff capacity building efforts are
below the axis.
Clinic staff capacity building
To increase staff capacity to deliver cessation care, we trained
each medical team member and clinic QI leaders (Figure
1). Medical assistants received training on how to
document patients’ smoking status in the HER, and how to provide
a cessation referral. Healthcare providers and pharmacists
received training on how to provide and document cessation
counseling in the HER. Behavioral assistants received training
on how to access a “missed opportunities” list in the HER, that
is, a list of patients who did not receive a cessation service
during their primary care visit for proactive telephone
outreach. Behavioral assistants also received training on how to
provide motivational interviewing for cessation coaching, and
how to document the telephone outreach in the HER. Clinic QI
leads like medical directors, nurse managers, and QI data
analysts received training on how to access data on missed
opportunities to provide cessation care, and staff performance
around smoking cessation. We shared weekly data on cessation
referral and counseling to each of the 13 clinics. The data
allowed clinics to examine their progress over time, identify
opportunities to make improvements, and assess their performance
in comparison to other clinics in the network. These capacity
building efforts were ongoing from March 2020 to February 2022.
The SFHN uses the plan-do-study-act cycle
as a QI framework to develop, test, and implement
practice changes throughout the health system. We used the same
QI framework to develop, test, and implement these outreach and
capacity building initiatives during the COVID-19 pandemic.
Measurements
We examined trends in 3 metrics between February 2020 and February 2022:
(1) tobacco use screening, (2) healthcare provider counseling, and (3)
best practice in delivering cessation care. We defined “best practice”
as delivering at least 1 smoking cessation service (ie, medical
assistant referral, healthcare provider counseling, behavioral
assistant coaching, and pharmacotherapy) during a primary care visit.
We set the goal for best practice at 60% (ie, each week, at least 60%
of patients who smoked received a cessation service during their
visit), which was the average for the top 7 performing clinics in June
2020. Because best practice is an aggregate measure of all cessation
services, we used this metric to assess delivery of cessation services
between African American/Black and other patients.
Results
Receipt of Cessation Services Before and After Adaptations for
Telehealth
In March 2020, the tobacco registry included 6,884 adults who smoked, of
whom 64% (N = 4425) had received at least 1 cessation service in the
past 2 years. By the end of the study (February 2022), the registry
included 9593 patients who smoked, of whom 76% (N = 7336) received at
least 1 cessation service in the past 2 years.
Primary Care Visits and Delivery of Tobacco Screening
In February 2020, there were a total of 10,042 primary care visits, of
which 99% were in person (Figure 2). The percentage of
in-person visits dropped at the onset of the pandemic and was at its
lowest (20%) in April 2020. By February 2022, the in-person visits
gradually increased to 67%. Conversely, only 1% of primary care visits
were conducted by telephone in February 2020. However, telehealth
visits were at their highest (80%) in April 2020, and gradually
decreased to 33% in February 2022. In February 2020, tobacco screening
was 73%, and declined to 29% in April 2020 in parallel with a decline
in in-person visits. Over the study duration, with adaptations to the
telehealth model, tobacco screening increased to 74% by February
2022.
Figure 2.
Trends in in-person and telehealth primary care visits and
tobacco screening during primary care visits from February
2020 to February 2022.
Trends in in-person and telehealth primary care visits and
tobacco screening during primary care visits from February
2020 to February 2022.
Delivery of Healthcare Provider Counseling
Telehealth counseling was the primary method of provider counseling
between March 2020 to March 2021; on average, 34% more patients
received provider counseling over the telephone than in-person (Figure 3).
However, the trend reversed between April 2021 and February 2022 as
more primary care visits were taking place in person. From April 2021
to February 2022, an average of 23% more patients received in-person
counseling than telehealth counseling.
Figure 3.
Percentage of in-person and telehealth counseling among those
who received healthcare provider counseling during primary
care visits from March 2020 to February 2022.
Percentage of in-person and telehealth counseling among those
who received healthcare provider counseling during primary
care visits from March 2020 to February 2022.
Delivery of Best Practice Cessation Care
In June 2020, best practice care for all patients was 41%: 39% for
African American/Black and 42% for other patients (Figure 4). By
February 2022, best practice care increased to 64%: 63% for African
American/Black patients and 65% for other patients. Best practice care
increased by 23% between June 2020 and February 2022. Between
September 2021 and February 2022, the gap in best practice care for
African American/Black patients and other patients appeared to have
closed.
Figure 4.
Trends in best practice for smoking cessation care for
African/American Black and other patients from June 2020
to February 2022. Best practice for smoking cessation care
includes providing at least 1 cessation service during a
primary care encounter.
Trends in best practice for smoking cessation care for
African/American Black and other patients from June 2020
to February 2022. Best practice for smoking cessation care
includes providing at least 1 cessation service during a
primary care encounter.
Discussion
From March 2020 to February 2022, the SFHN implemented telehealth adaptations
and QI initiatives to improve delivery of tobacco cessation care during the
COVID-19 pandemic. With patient outreach and staff capacity building
efforts, we saw a 12% increase (64%-76%) in the percentage of tobacco
registry patients who received at least 1 cessation service. Tobacco
screening increased by 45% (29%-74%) and best practice increased by 23% with
no observed disparity in the delivery of cessation care between African
American/Black and other patients during the latter 6 months of the
pandemic.The SFHN has a multidisciplinary population health team that monitors the
SFHN’s performance on several primary care measures, including tobacco
screening and counseling.[19,27,28] The SFHN also had
a dedicated tobacco coordinator trained in clinic-facing tasks and data
analytics. The coordinator worked with the information technology (IT) staff
to build, operationalize, and improve the tobacco-focused disease
registries. The coordinator’s clinic-facing tasks included building rapport
with clinic staff and leadership to support the use of the disease
registries, train staff on providing counseling and documenting efforts in
the HER, and assist clinics in meeting the 60% best-practice goal. The
population health team, including dedicated staff to address tobacco use,
and the IT infrastructure were critical to transitioning cessation services
in the SFHN to a telehealth model.While there were some differences in delivery of cessation care between African
American/Black and other patients during the pandemic, these gaps appeared
to close toward the end of the study time frame. Clinics that served a
higher proportion of African American/Black patients were located in
neighborhoods that were heavily impacted by COVID-19. The SFHN deployed
staff in those clinics to COVID-19 operations, and they had less capacity to
focus on tobacco cessation services even as they saw a large volume of
African American/Black patients who smoked. These factors may have
contributed to differences in best practice care between African
American/Black patients and other patients. As COVID-19 operations reduced,
those clinics shifted resources to QI efforts, dedicating staff as QI
leaders to address gaps in care. To further support these clinics, the
tobacco coordinator and population health team provided consultations weekly
and on an as needed basis on how to use clinic-level data to address missed
opportunities in providing cessation care and to improve best practices.
These efforts may have contributed to the overall increase in best practice
and a decrease in the gap in cessation services for African American/Black
and other patients.The tobacco coordinator regularly engaged with medical assistants and their
supervisors to share weekly staff performance data on the number of patients
screened and counseled, and to reinforce training on documentation of
tobacco screening and cessation referrals. We found that healthcare
providers reported having less capacity to focus on tobacco cessation
counseling during the COVID-19 pandemic. Our findings highlight a role for
cessation efforts that do not solely rely on staff to integrate cessation
counseling into primary care. Interventions that use the HER to submit
electronic referrals to the Helpline hold promise for increasing access to
cessation counseling for some patients in the safety-net health
system.[29,30]There are several limitations to our study. As the purpose of QI is different
from that of clinical research, our QI interventions did not rely on
randomized controlled trial methods or a control group. Instead, we
continuously evaluated and modified interventions using PDSA cycles.
Like tobacco, other primary care metrics such as cancer screenings
declined at the onset of the pandemic.
Although we cannot draw causal inferences between the QI efforts
described in this study and tobacco cessation services, we observed an
increase in tobacco screening and counseling that could be associated with
these efforts. Simultaneously, other primary care metrics that the SFHN did
not address systematically through QI efforts declined further or stayed the
same. Smoking status was self-reported, potentially leading to a
misclassification bias. However, the population health team validated the
HER data by manual chart review to ensure that the quality of smoking
assessments and receipt of counseling were accurate, reducing the potential
for misclassification bias.In conclusion, we found that adaptations to the EHR and team-based care model
can increase telehealth delivery of tobacco cessation services in a large
safety-net health system. The adaptations relied on a multidisciplinary team
to implement the changes and facilitate rapid QI cycles. Proactive telephone
outreach may offer cessation referrals to some patients, but other methods
are needed to increase delivery of cessation counseling within safety-net
systems. Targeted and personalized interventions that dynamically adapt to
the needs and context of each clinic may more effectively improve health
system services and tobacco-related health equity.
Authors: Jennifer M Schindler-Ruwisch; Lorien C Abroms; Steven L Bernstein; Christina L Heminger Journal: Transl Behav Med Date: 2017-06 Impact factor: 3.046
Authors: Mark D Schwartz; Ashley Jensen; Binhuan Wang; Katelyn Bennett; Anne Dembitzer; Shiela Strauss; Antoinette Schoenthaler; Colleen Gillespie; Scott Sherman Journal: J Gen Intern Med Date: 2015-02-10 Impact factor: 5.128
Authors: Alex H Krist; Karina W Davidson; Carol M Mangione; Michael J Barry; Michael Cabana; Aaron B Caughey; Katrina Donahue; Chyke A Doubeni; John W Epling; Martha Kubik; Gbenga Ogedegbe; Lori Pbert; Michael Silverstein; Melissa A Simon; Chien-Wen Tseng; John B Wong Journal: JAMA Date: 2021-01-19 Impact factor: 56.272
Authors: Noah R Gubner; Denise D Williams; Ellen Chen; David Silven; Janice Y Tsoh; Joseph Guydish; Maya Vijayaraghavan Journal: Prev Med Rep Date: 2019-05-22
Authors: Lisa M Fucito; Krysten W Bold; Sydney Cannon; Alison Serrantino; Rebecca Marrero; Stephanie S O'Malley Journal: Int J Environ Res Public Health Date: 2022-07-06 Impact factor: 4.614